PMID- 31480861 OWN - NLM STAT- MEDLINE DCOM- 20200526 LR - 20200831 IS - 1530-6860 (Electronic) IS - 0892-6638 (Print) IS - 0892-6638 (Linking) VI - 33 IP - 11 DP - 2019 Nov TI - T-cell-derived extracellular vesicles regulate B-cell IgG production via pyruvate kinase muscle isozyme 2. PG - 12780-12799 LID - 10.1096/fj.201900863R [doi] AB - Intercellular communication between lymphocytes plays a fundamental role in numerous immune responses. Previously, we demonstrated that hyperhomocysteinemia (HHcy) induced T cell intracellular glycolytic-lipogenic reprogramming and IFN-gamma secretion via pyruvate kinase muscle isozyme 2 (PKM2) to accelerate atherosclerosis. Usually, B cells partially obtain help from T cells in antibody responses. However, whether PKM2 activation in T cells regulates B cell antibody production is unknown. Extracellular vesicles (EVs) are important cellular communication vehicles. Here, we found that PKM2 activator TEPP46-stimulated T-cell-derived EVs promoted B-cell IgG secretion. Conversely, EVs secreted from PKM2-null T cells were internalized into B cells and markedly inhibited B-cell mitochondrial programming, activation, and IgG production. Mechanistically, lipidomics analyses showed that increased ceramides in PKM2-activated T-cell EVs were mainly responsible for enhanced B cell IgG secretion induced by these EVs. Finally, quantum dots (QDs) were packaged with PKM2-null T cell EVs and anti-CD19 antibody to exert B-cell targeting and inhibit IgG production, eventually ameliorating HHcy-accelerated atherosclerosis in vivo. Thus, PKM2-mediated EV ceramides in T cells may be an important cargo for T-cell-regulated B cell IgG production, and QD-CD19-PKM2-null T cell EVs hold high potential to treat B cell overactivation-related diseases.-Yang, J., Dang, G., Lu, S., Liu, H., Ma, X., Han, L., Deng, J., Miao, Y., Li, X., Shao, F., Jiang, C., Xu, Q., Wang, X., Feng, J. T-cell-derived extracellular vesicles regulate B-cell IgG production via pyruvate kinase muscle isozyme 2. FAU - Yang, Juan AU - Yang J AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Dang, Guohui AU - Dang G AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Lu, Silin AU - Lu S AD - State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. FAU - Liu, Huiying AU - Liu H AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Ma, Xiaolong AU - Ma X AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Han, Lulu AU - Han L AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Deng, Jiacheng AU - Deng J AD - Cardiovascular Division, British Heart Foundation (BHF) Centre for Vascular Regeneration, King's College London, London, United Kingdom. FAU - Miao, Yutong AU - Miao Y AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Li, Xiaopeng AU - Li X AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Shao, Fangyu AU - Shao F AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Jiang, Changtao AU - Jiang C AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Xu, Qingbo AU - Xu Q AD - Cardiovascular Division, British Heart Foundation (BHF) Centre for Vascular Regeneration, King's College London, London, United Kingdom. FAU - Wang, Xian AU - Wang X AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. FAU - Feng, Juan AU - Feng J AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190831 PL - United States TA - FASEB J JT - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JID - 8804484 RN - 0 (Immunoglobulin G) RN - 0 (Isoenzymes) RN - EC 2.7.1.40 (Pkm protein, mouse) RN - EC 2.7.1.40 (Pyruvate Kinase) SB - IM MH - Animals MH - *Antibody Formation MH - B-Lymphocytes/*immunology/pathology MH - Extracellular Vesicles/*immunology/pathology MH - Female MH - Immune System Diseases/immunology/pathology/therapy MH - Immunoglobulin G/*immunology MH - Isoenzymes/immunology MH - Mice MH - Mice, Knockout, ApoE MH - Pyruvate Kinase/*immunology MH - Quantum Dots MH - T-Lymphocytes/*immunology/pathology PMC - PMC6902684 OTO - NOTNLM OT - antibody OT - ceramide OT - lymphocyte COIS- The authors are grateful to Prof. Wei Kong (Peking University) for the helpful advice. The authors thank Prof. Shiqiang Wang, Prof. Xuemei Hao, and Prof. Yingchun Hu (Peking University) for assistance with the extracellular vesicle transmission electron microscope assays. This work was supported by the National Natural Science Foundation of China (91739303 and 81770445). The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the article. The authors were not paid to write this manuscript by a pharmaceutical company or other agency. The authors declare no conflicts of interest. EDAT- 2019/09/05 06:00 MHDA- 2020/05/27 06:00 PMCR- 2020/08/31 CRDT- 2019/09/05 06:00 PHST- 2019/09/05 06:00 [pubmed] PHST- 2020/05/27 06:00 [medline] PHST- 2019/09/05 06:00 [entrez] PHST- 2020/08/31 00:00 [pmc-release] AID - FJ_201900863R [pii] AID - 10.1096/fj.201900863R [doi] PST - ppublish SO - FASEB J. 2019 Nov;33(11):12780-12799. doi: 10.1096/fj.201900863R. Epub 2019 Aug 31.